SCHEMBL3391121

SCHEMBL3391121

COC(=O)c1nn(C)c(C(C)C)c1N

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.39
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 3/20 0.34
GAA P10253 2/20 0.34
TP53 P04637 2/20 0.34
NPBWR1 P48145 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CASP1 P29466 1/20 0.33
MAPT P10636 3/20 0.33
TSHR P16473 1/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6632048 0.81 ADORA2A (0.36) ALDH1A1KDM4EGAAKMT2ALMNA
SCHEMBL31133143 0.77 NPSR1 (0.43) NPSR1ALDH1A1KDM4EGAATP53
SCHEMBL7004410 0.75 NPSR1 (0.41) NPSR1ALDH1A1KDM4EGAATP53
Iodomethane SCHEMBL3389060 0.74 MEN1 (0.40) NPSR1ALDH1A1GAAPOLBKMT2A
SCHEMBL18878421 0.70 NPSR1 (0.39) NPSR1ALDH1A1KDM4EGAATP53
SCHEMBL22659694 0.68 NPSR1 (0.45) NPSR1ALDH1A1KDM4EGAATP53
SCHEMBL6996899 0.68 NPSR1 (0.36) NPSR1ALDH1A1KDM4EGAATP53
SCHEMBL7792914 0.68 ALDH1A1 (0.57) NPSR1ALDH1A1KDM4EGAATP53
SCHEMBL21621672 0.67 NPSR1 (0.43) NPSR1ALDH1A1KDM4EGAAPOLB
SCHEMBL21637130 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010043633-A1 2H-PYRAZOLO [4,3-D]PYRIMIDIN-5-AMINE DERIVATIVES AS H4 HISTAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ALLERGIC, IMMUNOLOGICAL AND INFLAMMATORY DISEASES PALAU PHARMA, S. A. (ES) 2010-04-22 WO disclosed